| Product NDC: | 64281-100 |
| Proprietary Name: | Provocholine |
| Non Proprietary Name: | methacholine chloride |
| Active Ingredient(s): | 100 mg/100mg & nbsp; methacholine chloride |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64281-100 |
| Labeler Name: | Methapharm Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019193 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130327 |
| Package NDC: | 64281-100-06 |
| Package Description: | 6 VIAL, GLASS in 1 BOX (64281-100-06) > 100 mg in 1 VIAL, GLASS (64281-100-00) |
| NDC Code | 64281-100-06 |
| Proprietary Name | Provocholine |
| Package Description | 6 VIAL, GLASS in 1 BOX (64281-100-06) > 100 mg in 1 VIAL, GLASS (64281-100-00) |
| Product NDC | 64281-100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methacholine chloride |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20130327 |
| Marketing Category Name | NDA |
| Labeler Name | Methapharm Inc. |
| Substance Name | METHACHOLINE CHLORIDE |
| Strength Number | 100 |
| Strength Unit | mg/100mg |
| Pharmaceutical Classes | Cholinergic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |